Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
TheStreet.com
Thursday, April 3, 2014 - 8:58am
tags:
FDA, Northwest Biotherapeutics, glioblastoma multiforme, DCVax
GlaxoSmithKline yanks Paxil batches after FDA warning letter
Fierce Pharma
Wednesday, April 2, 2014 - 10:03pm
tags:
FDA, Paxil, warnings, GSK
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Wednesday, April 2, 2014 - 10:01pm
tags:
Gilead Sciences, Japan, hepatitis C, sofosbuvir
Amarin triples size of Vascepa sales force with Kowa promo deal
Fierce Pharma
Wednesday, April 2, 2014 - 9:53pm
tags:
Kowa, hirings, Amarin, drug reps, Vascepa
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
Seeking Alpha
Wednesday, April 2, 2014 - 9:52pm
tags:
Bydureon, insulin, Bristol-Myers Squibb, diabetes
The Medicines Co. Falls on Angiomax Woes
Yahoo/Zacks.com
Wednesday, April 2, 2014 - 9:51pm
tags:
Angiomax, The Medicines Company, patents
IPO Preview: Scynexis
Seeking Alpha
Wednesday, April 2, 2014 - 9:46pm
tags:
IPOs, Scynexis, anti-infectives
Sanofi eyes more acquisitions, sees growth in Africa
Yahoo/Reuters
Wednesday, April 2, 2014 - 9:44pm
tags:
Sanofi, Africa, M&A, Chris Viehbacher
IPO Preview: Corium International
Seeking Alpha
Wednesday, April 2, 2014 - 9:42pm
tags:
IPOs, Corium International, transdermal drug delivery
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wednesday, April 2, 2014 - 9:41pm
tags:
Sovaldi, hepatitis C, Gilead Sciences
Myriad shares soar after Medicare reimbursements get a 37% boost
Marketwatch
Wednesday, April 2, 2014 - 9:40pm
tags:
Medicare, Myriad Genetics
FDA defends generic drug label proposal at U.S. House hearing
Yahoo/Reuters
Wednesday, April 2, 2014 - 7:48am
tags:
FDA, generics, labeling
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wednesday, April 2, 2014 - 7:46am
tags:
FDA, Afrezza, diabetes, MannKind
A Second Lawsuit Tests the BPCIA Biosimilars “Patent Dance” Waters
FDA Law Blog
Wednesday, April 2, 2014 - 7:45am
tags:
patents, biosimilars, Celltrion, Janssen Biotech, Remicade
Danone-Mead Johnson Would Make Baby Food Giant: Real M&A
Bloomberg
Wednesday, April 2, 2014 - 7:33am
tags:
Danone, Mead Johnson, infant nutrition, M&A
Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery
Yahoo
Wednesday, April 2, 2014 - 7:31am
tags:
Illumina, oncology, drug discovery, next-generation gene sequencing
Europe Moves to Make Drug Trial Data More Transparent
Bloomberg/Businessweek
Wednesday, April 2, 2014 - 7:29am
tags:
Europe, clinical trial data, transparency
Boston Scientific reports favorable results in MADIT-CRT study
Yahoo/Fly on the Wall
Wednesday, April 2, 2014 - 7:28am
tags:
devices, Boston Scientific, cardiac resynchronization therapy, platinum chromium stent platforms, TAVR
GlaxoSmithKline throws in towel on lung cancer vaccine trial
Yahoo/Reuters
Wednesday, April 2, 2014 - 7:26am
tags:
GSK, vaccines, non-small cell lung cancer, MAGE-A3
Biotech Auxilium Boosts Position In Men's Health Care
Investors.com
Wednesday, April 2, 2014 - 7:25am
tags:
Auxilium, erectile dysfunction, testosterone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.